During the past decade, Northern Virginia Pelvic Surgery Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Virginia Pelvic Surgery Associates" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Morphotek" with 3 trials sponsored, "GOG Foundation" with 2 trials sponsored, "Ethicon, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Virginia Pelvic Surgery Associates" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Northern Virginia Pelvic Surgery Associates" are "Ovarian Cancer" (6 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (4 trials), "Fallopian Tube Mucinous Adenocarcinoma" (4 trials), "Fallopian Tube Transitional Cell Carcinoma" (4 trials) and "Ovarian Endometrioid Adenocarcinoma" (4 trials). Many other conditions were trialed in "Northern Virginia Pelvic Surgery Associates" in a lesser frequency.

Most popular intervention types in "Northern Virginia Pelvic Surgery Associates" are "Drug" (13 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (7 trials), "Carboplatin" (6 trials), "Laboratory Biomarker Analysis" (5 trials), "Quality-of-Life Assessment" (5 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Northern Virginia Pelvic Surgery Associates" are 14 trials for "Female" genders.

Currently, there are NaN active trials in "Northern Virginia Pelvic Surgery Associates". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Northern Virginia Pelvic Surgery Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Virginia Pelvic Surgery Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".